XENETIX

This brand name is authorized in Austria, Croatia, Ecuador, France, Hong Kong SAR China, Ireland, Romania, Singapore, South Africa, Spain, Tunisia.

Active ingredients

The drug XENETIX contains one active pharmaceutical ingredient (API):

1	Iobitriol UNII 182ECH14UH - IOBITRIDOL
	Iobitriol is a urographic and angiographic water-soluble nonionic contrast agent.
	Read more about Iobitriol

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
XENETIX Solution for injection	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
V08AB11	Iobitridol	V Various → V08 Contrast media → V08A X-ray contrast media, iodinated → V08AB Watersoluble, nephrotropic, low osmolar X-ray contrast media
Discover more medicines within V08AB11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	29163-02-10
ES	Centro de información online de medicamentos de la AEMPS	61384, 61385
FR	Base de données publique des médicaments	60407463, 66613769, 68324489
HK	Department of Health Drug Office	41350, 41351, 63260, 63261, 63262, 63263
HR	Agencija za lijekove i medicinske proizvode	HR-H-019109441, HR-H-979525408
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W43191001, W43191002, W43191003, W43192001, W43192002, W43192003
SG	Health Sciences Authority	08866P, 08867P, 08879P
TN	Direction de la Pharmacie et du Médicament	5643031, 5643032, 5643034, 5643036, 5643037, 5643038
ZA	Health Products Regulatory Authority	31/28/0552, 31/28/0553, 31/28/0554